INDP Indaptus Therapeutics Inc
Company Analysis
Latest News
🔴 Indaptus Therapeutics is trading 17.2% down today as Friday's selloff extends amid profit-taking
Indaptus Therapeutics is trading at $2.09 (17.2% down) today as early pre-market strength faded and Friday’s selloff extended into the new week. • The decline...
🔴 Indaptus Therapeutics is trading 7.3% down today as pre-market gains reverse
Indaptus Therapeutics is trading at $2.42 (-7.28%) as the stock reverses its earlier pre-market rebound. • The decline follows a selloff on Friday, with the...
🟢 Indaptus Therapeutics is trading 10% up today as it rebounds from Friday's pullback
Indaptus Therapeutics is trading at $2.87 (+10%) in pre-market, staging a recovery after shares fell approximately 5–7% during Friday's profit-taking...
🔴 Indaptus Therapeutics is trading 7.4% down today on profit-taking after recent gains
Indaptus Therapeutics is trading 7.4% down at $2.56 as the stock pulls back following several days of sharp gains earlier this week. • The move comes in the...
🔴 Indaptus Therapeutics is trading 6.1% down today with no clear catalyst
Indaptus Therapeutics is trading 6.1% down at $2.60 in pre-market sessions after several days of steady gains earlier this week. • There are no fresh...
🔴 Indaptus Therapeutics is trading 5.1% down today amid broader market weakness
Indaptus Therapeutics is trading 5.1% down at $2.40 today, appearing to track broader market volatility as the Nasdaq Composite declines 1.54%. • The move...
🔴 Indaptus Therapeutics is trading 10.1% down
Indaptus Therapeutics is trading at $2.54, down 10.1% from a comparison close of $2.82 during regular trading. This is a price-action follow-up, so a separate...
🔴 Indaptus Therapeutics is trading 6% down today as it consolidates after a recent rally
Indaptus Therapeutics is trading 6% down at $2.65 today, giving back a portion of its recent gains following a sharp move higher on July 15, 2026. * The stock...
🟢 Indaptus Therapeutics is trading 10.5% up
Indaptus Therapeutics is trading at $2.91, up 10.5% from a comparison close of $2.63 during regular trading. This is a price-action follow-up, so a separate...
🟢 Indaptus Therapeutics is trading 6.1% up today on broader risk-on sentiment
Indaptus Therapeutics is trading 6.1% up at $2.79 following several volatile sessions and a recent market rebound. • The move appears driven by broader...
🔴 Indaptus Therapeutics is trading 6.1% down today as it retreats from a recent rebound
Indaptus Therapeutics is trading at $2.47 (6.1% down), retreating from its recent rebound after experiencing sharp volatility in prior sessions. • There are...
🟢 Indaptus Therapeutics is trading 5.6% up today amid speculative trading
Indaptus Therapeutics is trading 5.6% up today at $2.64 amid speculative trading and market volatility, as no specific company catalysts or regulatory...
🔴 INDP extends move to 8.4% down
INDP is trading at $2.44, down 8.4% versus the comparison close of $2.67 during regular trading. This is a price-movement alert; no separate company-specific...
Indaptus Therapeutics Is Burning Cash, Selling Shares at a Steep Discount, and Asking Investors to Trust the Plan — Should They?
Shares of Indaptus Therapeutics (INDP) slid 7.9% to $2.46 on July 8, extending a brutal 28% decline from $3.41 on June 26. The selloff reflects a convergence...
🔴 INDP is trading 7.9% down today on dilution fears and financing uncertainty
INDP is trading 7.9% down today at $2.46 as concerns mount over the company's immediate cash needs and the potential for dilutive financing. • The stock...
🔴 INDP is trading 6.4% down today, extending a multi-day slide amid financing uncertainty
INDP is trading at $2.50 (6.4% down) in pre-market, extending a multi-day slide from $3.41 on June 26 to $2.67 on July 7. • The stock continues to face heavy...
🔴 INDP is trading 6% down today amid continued volatility and financing uncertainty
INDP is trading approximately 6% down today at $2.68 following a sharp drop in the previous session and ongoing market uncertainty. • No new company filings,...
🔴 INDP is trading 8.4% down today with no clear catalyst
INDP is trading 8.4% down at $2.61 with no clear company-specific catalyst emerging so far. • This pre-market weakness appears idiosyncratic, as there are no...
Indaptus Sells Shares at 81% Below Market to Stay Alive — Can $12 Million Buy Enough Time for a Clinical-Stage Biotech With No Revenue?
Shares of Indaptus Therapeutics shifted sharply this week as the clinical-stage cancer immunotherapy company announced a $12 million Regulation S private...
🟢 INDP is trading 8.5% up today after rebounding from discounted $12M placement
INDP is trading at 8.5% up now at $3.19, rebounding after a sharply discounted $12 million Regulation S private placement announced on July 1, 2026. The...